The most common variant, and thus the most important one, is the splicing variant AR-V7 (androgen receptor splice variant 7, also called AR3), which, in the cells of patients with hormone-refractory PCa (HRPC), shows a 20-fold higher expression, than in the cells of patients not previously treated with hormone-naive PCa [59]. This evidence concerns the gene AR and posterior cortical atrophy.